Nauzene is a Oral Tablet, Chewable in the Human Otc Drug category. It is labeled and distributed by Alva-amco Pharmacal Companies, Inc.. The primary component is Trisodium Citrate Dihydrate.
Product ID | 52389-242_6a4aa79d-5df2-0ad1-e053-2a91aa0a540b |
NDC | 52389-242 |
Product Type | Human Otc Drug |
Proprietary Name | Nauzene |
Generic Name | Sodium Citrate |
Dosage Form | Tablet, Chewable |
Route of Administration | ORAL |
Marketing Start Date | 2000-07-08 |
Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
Labeler Name | Alva-Amco Pharmacal Companies, Inc. |
Substance Name | TRISODIUM CITRATE DIHYDRATE |
Active Ingredient Strength | 230 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2016-07-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | unapproved drug other |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2000-07-08 |
Marketing Category | unapproved drug other |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-11-16 |
Marketing Category | unapproved drug other |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-07-15 |
Marketing Category | unapproved drug other |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2006-10-01 |
Marketing Category | unapproved drug other |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2017-07-06 |
Ingredient | Strength |
---|---|
TRISODIUM CITRATE DIHYDRATE | 230 mg/1 |
SPL SET ID: | a60660b2-c5db-45a0-885f-de93e655380d |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
52389-172 | Nauzene | Sodium Citrate |
52389-242 | Nauzene | Sodium Citrate |
62646-798 | Anticoagulant Sodium Citrate | Sodium Citrate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
NAUZENE 74469794 1909137 Live/Registered |
ALVA-AMCO PHARMACAL COS., INC. 1993-12-16 |